St John of God Subiaco Hospital is a private hospital in Subiaco, Western Australia, founded in 1898.

There are 578 beds in St. John of God Subiaco Hospital.

During the past decade, St. John of God Subiaco Hospital conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 16 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 10 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. John of God Subiaco Hospital" #1 sponsor was "Daiichi Sankyo, Inc." with 5 trials, followed by "Celgene" with 4 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 3 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 3 trials sponsored and "Clovis Oncology, Inc." with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. John of God Subiaco Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 6 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator, "Foundation Medicine" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "St. John of God Subiaco Hospital" are "Crohn Disease" (6 trials), "Breast Cancer" (5 trials), "Fallopian Tube Cancer" (5 trials), "Ovarian Cancer" (4 trials) and "Non-Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "St. John of God Subiaco Hospital" in a lesser frequency.

Most popular intervention types in "St. John of God Subiaco Hospital" are "Drug" (53 trials), "Other" (12 trials), "Biological" (11 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Gemcitabine" (5 trials), "Paclitaxel" (4 trials), "Pembrolizumab" (4 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. John of God Subiaco Hospital" are 45 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "St. John of God Subiaco Hospital". undefined are not yet recruiting, 18 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in St. John of God Subiaco Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. John of God Subiaco Hospital, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".